Prevalence of hepatitis C in a drug using and non-using welfare population
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Lorvick, J. & Kral, A.H. & Seal, K. & Gee, L. & Edlin, B.R., 2001. "Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif," American Journal of Public Health, American Public Health Association, vol. 91(1), pages 46-47.
- Garfein, R.S. & Vlahov, D. & Galai, N. & Doherty, M.C. & Nelson, K.E., 1996. "Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses," American Journal of Public Health, American Public Health Association, vol. 86(5), pages 655-661.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Lelutiu-Weinberger, Corina & Pouget, Enrique R. & Des Jarlais, Don D.C. & Cooper, Hannah L. & Scheinmann, Roberta & Stern, Rebecca & Strauss, Shiela M. & Hagan, Holly, 2009. "A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups," Social Science & Medicine, Elsevier, vol. 68(3), pages 579-590, February.
- Harold A. Pollack, 2001. "Can We Protect Drug Users from Hepatitis C?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 20(2), pages 358-364.
- Alexander Gutfraind & Basmattee Boodram & Nikhil Prachand & Atesmachew Hailegiorgis & Harel Dahari & Marian E Major, 2015. "Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-23, September.
- Harold A. Pollack, 2001. "Cost-effectiveness of Harm Reduction in Preventing Hepatitis C among Injection Drug Users," Medical Decision Making, , vol. 21(5), pages 357-367, October.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:64:y:2003:i:2:p:221-228. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.